Show simple item record

Reverse-Engineering a Transcriptional Enhancer: A Case Study in Drosophila

dc.contributor.authorJohnson, Lisa A.en_US
dc.contributor.authorZhao, Yingen_US
dc.contributor.authorGolden, Kristaen_US
dc.contributor.authorBarolo, Scotten_US
dc.date.accessioned2009-07-10T19:03:08Z
dc.date.available2009-07-10T19:03:08Z
dc.date.issued2008-09-01en_US
dc.identifier.citationJohnson, Lisa A.; Zhao, Ying; Golden, Krista; Barolo, Scott (2008). "Reverse-Engineering a Transcriptional Enhancer: A Case Study in Drosophila." Tissue Engineering Part A 14(9): 1549-1559 <http://hdl.handle.net/2027.42/63213>en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/63213
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18687053&dopt=citationen_US
dc.description.abstractAbstract Enhancers, or cis-regulatory elements, are the principal determinants of spatiotemporal patterning of gene expression. For reasons of clinical and research utility, it is desirable to build customized enhancers that drive novel gene expression patterns, but currently, we largely rely on “found” genomic elements. Synthetic enhancers, assembled from transcription factor binding sites taken from natural signal-regulated enhancers, generally fail to behave like their wild-type counterparts when placed in transgenic animals, suggesting that important aspects of enhancer function are still unexplored. As a step toward the creation of a truly synthetic regulatory element, we have undertaken an extensive structure–function study of an enhancer of the Drosophila decapentaplegic (dpp) gene that drives expression in the developing visceral mesoderm (VM). Although considerable past efforts have been made to dissect the dppVM enhancer, transgenic experiments presented here indicate that its activity cannot be explained by the known regulators alone. dppVM contains multiple, previously uncharacterized, regulatory sites, some of which exhibit functional redundancy. The results presented here suggest that even the best-studied enhancers must be further dissected before they can be fully understood, and before faithful synthetic elements based on them can be created. Implications for developmental genetics, mathematical modeling, and therapeutic applications are discussed.en_US
dc.format.extent766092 bytes
dc.format.extent2489 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherMary Ann Liebert, Inc., publishersen_US
dc.titleReverse-Engineering a Transcriptional Enhancer: A Case Study in Drosophilaen_US
dc.typeArticleen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid18687053en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/63213/1/ten.tea.2008.0074.pdf
dc.identifier.doidoi:10.1089/ten.tea.2008.0074en_US
dc.identifier.sourceTissue Engineering Part Aen_US
dc.identifier.sourceTissue Engineering Part Aen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.